Document Detail

Testosterone administration induces protection against global myocardial ischemia.
MedLine Citation:
PMID:  19862668     Owner:  NLM     Status:  MEDLINE    
We tested the hypothesis that chronic testosterone treatment would promote a cardioprotective phenotype against ischemia/reperfusion (I/R) injury. For this study, 3-month-old F344 male rats underwent sham-surgery, orchiectomy (ORX), or ORX plus 21 days testosterone treatment (1.0 mg testosterone/day). At sacrifice, cardiac performance was assessed in a working heart model of I/R (25 min of global ischemia and 45 min of reperfusion). ORX reduced serum testosterone by approximately 98% and testosterone administration elevated serum testosterone to a concentration of 4.6-fold over that of Sham-operated controls (p<0.05). ORX did not significantly impair recovery of cardiac performance following I/R, but did increase cardiac release of lactate dehydrogenase (LDH) during pre- and post-ischemia (p<0.05). Testosterone administration prevented the ORX-induced increase in LDH during both pre- and post-ischemia and increased post-ischemic recovery of aortic flow, cardiac output, cardiac work, left ventricular developed pressure, and contractility (p<0.05) during reperfusion. Testosterone administration also increased left ventricular expression of catalase, but did not affect the expression of manganese superoxide dismutase, glutathione peroxidase, or sarcolemmal K (ATP) channel protein Kir6.2. Neither circulating nor cardiac concentrations of estradiol were altered by either treatment. We conclude that administration of high-dose testosterone confers cardioprotection through yet to be identified androgen-dependent mechanism(s).
S E Borst; J C Quindry; J F Yarrow; C F Conover; S K Powers
Related Documents :
18538048 - Effects of a prophylactic or therapeutic application of perflubron emulsion on myocardi...
7995278 - Cardioprotective actions of potassium channel openers.
15571828 - Use of abciximab prior to primary angioplasty in stemi results in early recanalization ...
11825728 - Diltiazem during reperfusion preserves high energy phosphates by protection of mitochon...
17255818 - Percutaneous implantation of the pulmonary and aortic valves: indications and limitations.
16980878 - The future of therapeutic myocardial angiogenesis.
Publication Detail:
Type:  Journal Article     Date:  2009-10-27
Journal Detail:
Title:  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et m?tabolisme     Volume:  42     ISSN:  1439-4286     ISO Abbreviation:  Horm. Metab. Res.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-04     Completed Date:  2010-04-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0177722     Medline TA:  Horm Metab Res     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  122-9     Citation Subset:  IM    
Copyright Information:
Georg Thieme Verlag KG Stuttgart * New York.
Malcom Randall VA Medical Center, Gainesville, FL 32608-1197, USA. seborst@ufl .edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Androgens / administration & dosage*
Estradiol / metabolism
Heart / physiopathology*
L-Lactate Dehydrogenase / metabolism
Myocardial Ischemia / physiopathology,  prevention & control*
Myocardial Reperfusion Injury / physiopathology,  prevention & control*
Rats, Inbred F344
Testosterone / administration & dosage*
Reg. No./Substance:
0/Androgens; 50-28-2/Estradiol; 58-22-0/Testosterone; EC Dehydrogenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes.
Next Document:  HPTLC Densitometric Evaluation of Tissue Culture Extracts of Nothapodytes foetida Compared to Conven...